nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine monophosphate—PRKAB1—Metformin—polycystic ovary syndrome	0.684	1	CbGbCtD
Adenosine monophosphate—PRKAB2—adrenal cortex—polycystic ovary syndrome	0.00199	0.0159	CbGeAlD
Adenosine monophosphate—FBP1—adrenal cortex—polycystic ovary syndrome	0.00193	0.0153	CbGeAlD
Adenosine monophosphate—PYGL—adrenal cortex—polycystic ovary syndrome	0.00191	0.0152	CbGeAlD
Adenosine monophosphate—AMPD1—adrenal gland—polycystic ovary syndrome	0.0019	0.0151	CbGeAlD
Adenosine monophosphate—HINT1—embryo—polycystic ovary syndrome	0.00184	0.0147	CbGeAlD
Adenosine monophosphate—PRKAB2—endometrium—polycystic ovary syndrome	0.00178	0.0142	CbGeAlD
Adenosine monophosphate—AMPD1—vagina—polycystic ovary syndrome	0.00176	0.014	CbGeAlD
Adenosine monophosphate—Clofarabine—RRM2—polycystic ovary syndrome	0.00174	0.635	CrCbGaD
Adenosine monophosphate—FBP1—endometrium—polycystic ovary syndrome	0.00172	0.0137	CbGeAlD
Adenosine monophosphate—PYGL—endometrium—polycystic ovary syndrome	0.0017	0.0136	CbGeAlD
Adenosine monophosphate—PRKAB2—pituitary gland—polycystic ovary syndrome	0.00161	0.0128	CbGeAlD
Adenosine monophosphate—PRKAB2—adipose tissue—polycystic ovary syndrome	0.0016	0.0128	CbGeAlD
Adenosine monophosphate—PYGL—uterus—polycystic ovary syndrome	0.00157	0.0125	CbGeAlD
Adenosine monophosphate—FBP1—pituitary gland—polycystic ovary syndrome	0.00156	0.0124	CbGeAlD
Adenosine monophosphate—FBP1—adipose tissue—polycystic ovary syndrome	0.00155	0.0123	CbGeAlD
Adenosine monophosphate—PYGL—pituitary gland—polycystic ovary syndrome	0.00154	0.0123	CbGeAlD
Adenosine monophosphate—PYGL—adipose tissue—polycystic ovary syndrome	0.00153	0.0122	CbGeAlD
Adenosine monophosphate—HINT1—adrenal cortex—polycystic ovary syndrome	0.00151	0.012	CbGeAlD
Adenosine monophosphate—PRKAB2—adrenal gland—polycystic ovary syndrome	0.00144	0.0115	CbGeAlD
Adenosine monophosphate—FBP1—adrenal gland—polycystic ovary syndrome	0.00139	0.0111	CbGeAlD
Adenosine monophosphate—CREB1—embryo—polycystic ovary syndrome	0.00138	0.011	CbGeAlD
Adenosine monophosphate—PYGL—adrenal gland—polycystic ovary syndrome	0.00138	0.011	CbGeAlD
Adenosine monophosphate—HINT1—endometrium—polycystic ovary syndrome	0.00135	0.0107	CbGeAlD
Adenosine monophosphate—ADCY1—adrenal gland—polycystic ovary syndrome	0.00135	0.0107	CbGeAlD
Adenosine monophosphate—PRKAB2—female gonad—polycystic ovary syndrome	0.00134	0.0107	CbGeAlD
Adenosine monophosphate—PRKAB2—vagina—polycystic ovary syndrome	0.00133	0.0106	CbGeAlD
Adenosine monophosphate—FBP1—female gonad—polycystic ovary syndrome	0.0013	0.0103	CbGeAlD
Adenosine monophosphate—FBP1—vagina—polycystic ovary syndrome	0.00129	0.0103	CbGeAlD
Adenosine monophosphate—PYGL—female gonad—polycystic ovary syndrome	0.00128	0.0102	CbGeAlD
Adenosine monophosphate—PYGL—vagina—polycystic ovary syndrome	0.00128	0.0102	CbGeAlD
Adenosine monophosphate—HINT1—uterus—polycystic ovary syndrome	0.00124	0.0099	CbGeAlD
Adenosine monophosphate—HINT1—pituitary gland—polycystic ovary syndrome	0.00122	0.00972	CbGeAlD
Adenosine monophosphate—PIM1—adrenal cortex—polycystic ovary syndrome	0.00122	0.00972	CbGeAlD
Adenosine monophosphate—HINT1—adipose tissue—polycystic ovary syndrome	0.00122	0.00968	CbGeAlD
Adenosine monophosphate—FBP1—endocrine gland—polycystic ovary syndrome	0.00121	0.0096	CbGeAlD
Adenosine monophosphate—ACSS2—adrenal cortex—polycystic ovary syndrome	0.0012	0.00958	CbGeAlD
Adenosine monophosphate—APRT—adrenal cortex—polycystic ovary syndrome	0.0012	0.00958	CbGeAlD
Adenosine monophosphate—ACSL1—adrenal cortex—polycystic ovary syndrome	0.0012	0.00952	CbGeAlD
Adenosine monophosphate—PRKAB1—endometrium—polycystic ovary syndrome	0.00116	0.00921	CbGeAlD
Adenosine monophosphate—ACSS1—endometrium—polycystic ovary syndrome	0.00112	0.00893	CbGeAlD
Adenosine monophosphate—HINT1—adrenal gland—polycystic ovary syndrome	0.00109	0.00868	CbGeAlD
Adenosine monophosphate—PIM1—endometrium—polycystic ovary syndrome	0.00109	0.00867	CbGeAlD
Adenosine monophosphate—APRT—endometrium—polycystic ovary syndrome	0.00107	0.00856	CbGeAlD
Adenosine monophosphate—ACSS2—endometrium—polycystic ovary syndrome	0.00107	0.00856	CbGeAlD
Adenosine monophosphate—ACSL1—endometrium—polycystic ovary syndrome	0.00107	0.0085	CbGeAlD
Adenosine monophosphate—PRKAB1—uterus—polycystic ovary syndrome	0.00106	0.00848	CbGeAlD
Adenosine monophosphate—PRKAB1—pituitary gland—polycystic ovary syndrome	0.00105	0.00833	CbGeAlD
Adenosine monophosphate—PRKAB1—adipose tissue—polycystic ovary syndrome	0.00104	0.0083	CbGeAlD
Adenosine monophosphate—HINT1—female gonad—polycystic ovary syndrome	0.00102	0.0081	CbGeAlD
Adenosine monophosphate—ACSS1—pituitary gland—polycystic ovary syndrome	0.00101	0.00808	CbGeAlD
Adenosine monophosphate—HINT1—vagina—polycystic ovary syndrome	0.00101	0.00805	CbGeAlD
Adenosine monophosphate—CREB1—endometrium—polycystic ovary syndrome	0.00101	0.00805	CbGeAlD
Adenosine monophosphate—ACSS1—adipose tissue—polycystic ovary syndrome	0.00101	0.00804	CbGeAlD
Adenosine monophosphate—PIM1—uterus—polycystic ovary syndrome	0.001	0.00799	CbGeAlD
Adenosine monophosphate—Cladribine—RRM2—polycystic ovary syndrome	0.000997	0.365	CrCbGaD
Adenosine monophosphate—ACSS2—uterus—polycystic ovary syndrome	0.00099	0.00789	CbGeAlD
Adenosine monophosphate—APRT—uterus—polycystic ovary syndrome	0.00099	0.00789	CbGeAlD
Adenosine monophosphate—PIM1—pituitary gland—polycystic ovary syndrome	0.000986	0.00785	CbGeAlD
Adenosine monophosphate—ACSL1—uterus—polycystic ovary syndrome	0.000984	0.00783	CbGeAlD
Adenosine monophosphate—PIM1—adipose tissue—polycystic ovary syndrome	0.000982	0.00782	CbGeAlD
Adenosine monophosphate—SRC—embryo—polycystic ovary syndrome	0.000973	0.00775	CbGeAlD
Adenosine monophosphate—APRT—pituitary gland—polycystic ovary syndrome	0.000972	0.00774	CbGeAlD
Adenosine monophosphate—ACSS2—pituitary gland—polycystic ovary syndrome	0.000972	0.00774	CbGeAlD
Adenosine monophosphate—ACSS2—adipose tissue—polycystic ovary syndrome	0.000968	0.00771	CbGeAlD
Adenosine monophosphate—APRT—adipose tissue—polycystic ovary syndrome	0.000968	0.00771	CbGeAlD
Adenosine monophosphate—ACSL1—pituitary gland—polycystic ovary syndrome	0.000966	0.00769	CbGeAlD
Adenosine monophosphate—ACSL1—adipose tissue—polycystic ovary syndrome	0.000962	0.00766	CbGeAlD
Adenosine monophosphate—HINT1—endocrine gland—polycystic ovary syndrome	0.000945	0.00753	CbGeAlD
Adenosine monophosphate—PRKAB1—adrenal gland—polycystic ovary syndrome	0.000934	0.00744	CbGeAlD
Adenosine monophosphate—CREB1—uterus—polycystic ovary syndrome	0.000931	0.00741	CbGeAlD
Adenosine monophosphate—CREB1—pituitary gland—polycystic ovary syndrome	0.000914	0.00728	CbGeAlD
Adenosine monophosphate—PRKAA1—adipose tissue—polycystic ovary syndrome	0.00091	0.00725	CbGeAlD
Adenosine monophosphate—CREB1—adipose tissue—polycystic ovary syndrome	0.00091	0.00725	CbGeAlD
Adenosine monophosphate—ACSS1—adrenal gland—polycystic ovary syndrome	0.000906	0.00722	CbGeAlD
Adenosine monophosphate—PIM1—adrenal gland—polycystic ovary syndrome	0.00088	0.00701	CbGeAlD
Adenosine monophosphate—PRKAB1—female gonad—polycystic ovary syndrome	0.000871	0.00694	CbGeAlD
Adenosine monophosphate—ACSS2—adrenal gland—polycystic ovary syndrome	0.000869	0.00692	CbGeAlD
Adenosine monophosphate—APRT—adrenal gland—polycystic ovary syndrome	0.000869	0.00692	CbGeAlD
Adenosine monophosphate—PRKAB1—vagina—polycystic ovary syndrome	0.000866	0.0069	CbGeAlD
Adenosine monophosphate—ACSL1—adrenal gland—polycystic ovary syndrome	0.000863	0.00687	CbGeAlD
Adenosine monophosphate—PDE4D—adipose tissue—polycystic ovary syndrome	0.000852	0.00679	CbGeAlD
Adenosine monophosphate—ACSS1—female gonad—polycystic ovary syndrome	0.000845	0.00673	CbGeAlD
Adenosine monophosphate—ACSS1—vagina—polycystic ovary syndrome	0.00084	0.00669	CbGeAlD
Adenosine monophosphate—PIM1—female gonad—polycystic ovary syndrome	0.000821	0.00654	CbGeAlD
Adenosine monophosphate—PRKAA1—adrenal gland—polycystic ovary syndrome	0.000817	0.0065	CbGeAlD
Adenosine monophosphate—CREB1—adrenal gland—polycystic ovary syndrome	0.000817	0.0065	CbGeAlD
Adenosine monophosphate—PIM1—vagina—polycystic ovary syndrome	0.000816	0.0065	CbGeAlD
Adenosine monophosphate—PRKAB1—endocrine gland—polycystic ovary syndrome	0.00081	0.00645	CbGeAlD
Adenosine monophosphate—APRT—female gonad—polycystic ovary syndrome	0.00081	0.00645	CbGeAlD
Adenosine monophosphate—ACSS2—female gonad—polycystic ovary syndrome	0.00081	0.00645	CbGeAlD
Adenosine monophosphate—ACSS2—vagina—polycystic ovary syndrome	0.000805	0.00641	CbGeAlD
Adenosine monophosphate—APRT—vagina—polycystic ovary syndrome	0.000805	0.00641	CbGeAlD
Adenosine monophosphate—ACSL1—female gonad—polycystic ovary syndrome	0.000805	0.00641	CbGeAlD
Adenosine monophosphate—ACSL1—vagina—polycystic ovary syndrome	0.0008	0.00637	CbGeAlD
Adenosine monophosphate—ADK—adrenal cortex—polycystic ovary syndrome	0.000786	0.00626	CbGeAlD
Adenosine monophosphate—ACSS1—endocrine gland—polycystic ovary syndrome	0.000786	0.00626	CbGeAlD
Adenosine monophosphate—PDE4D—adrenal gland—polycystic ovary syndrome	0.000765	0.00609	CbGeAlD
Adenosine monophosphate—PIM1—endocrine gland—polycystic ovary syndrome	0.000763	0.00608	CbGeAlD
Adenosine monophosphate—CREB1—female gonad—polycystic ovary syndrome	0.000761	0.00607	CbGeAlD
Adenosine monophosphate—PRKAA1—female gonad—polycystic ovary syndrome	0.000761	0.00607	CbGeAlD
Adenosine monophosphate—CREB1—vagina—polycystic ovary syndrome	0.000757	0.00603	CbGeAlD
Adenosine monophosphate—ACSS2—endocrine gland—polycystic ovary syndrome	0.000753	0.006	CbGeAlD
Adenosine monophosphate—APRT—endocrine gland—polycystic ovary syndrome	0.000753	0.006	CbGeAlD
Adenosine monophosphate—ACSL1—endocrine gland—polycystic ovary syndrome	0.000748	0.00596	CbGeAlD
Adenosine monophosphate—PDE4D—female gonad—polycystic ovary syndrome	0.000713	0.00568	CbGeAlD
Adenosine monophosphate—PRKAA1—endocrine gland—polycystic ovary syndrome	0.000708	0.00564	CbGeAlD
Adenosine monophosphate—CREB1—endocrine gland—polycystic ovary syndrome	0.000708	0.00564	CbGeAlD
Adenosine monophosphate—ADK—endometrium—polycystic ovary syndrome	0.000702	0.00559	CbGeAlD
Adenosine monophosphate—SRC—adipose tissue—polycystic ovary syndrome	0.000641	0.00511	CbGeAlD
Adenosine monophosphate—ADK—pituitary gland—polycystic ovary syndrome	0.000635	0.00506	CbGeAlD
Adenosine monophosphate—ADK—adipose tissue—polycystic ovary syndrome	0.000632	0.00504	CbGeAlD
Adenosine monophosphate—SRC—adrenal gland—polycystic ovary syndrome	0.000575	0.00458	CbGeAlD
Adenosine monophosphate—ADK—adrenal gland—polycystic ovary syndrome	0.000567	0.00452	CbGeAlD
Adenosine monophosphate—SRC—female gonad—polycystic ovary syndrome	0.000536	0.00427	CbGeAlD
Adenosine monophosphate—ADK—female gonad—polycystic ovary syndrome	0.000529	0.00421	CbGeAlD
Adenosine monophosphate—ADK—vagina—polycystic ovary syndrome	0.000526	0.00419	CbGeAlD
Adenosine monophosphate—PDE4B—endometrium—polycystic ovary syndrome	0.000499	0.00398	CbGeAlD
Adenosine monophosphate—SRC—endocrine gland—polycystic ovary syndrome	0.000499	0.00397	CbGeAlD
Adenosine monophosphate—ADK—endocrine gland—polycystic ovary syndrome	0.000492	0.00392	CbGeAlD
Adenosine monophosphate—PDE4B—pituitary gland—polycystic ovary syndrome	0.000452	0.0036	CbGeAlD
Adenosine monophosphate—PDE4B—adipose tissue—polycystic ovary syndrome	0.00045	0.00358	CbGeAlD
Adenosine monophosphate—PDE4B—adrenal gland—polycystic ovary syndrome	0.000403	0.00321	CbGeAlD
Adenosine monophosphate—PDE4B—female gonad—polycystic ovary syndrome	0.000376	0.003	CbGeAlD
Adenosine monophosphate—PDE4B—vagina—polycystic ovary syndrome	0.000374	0.00298	CbGeAlD
Adenosine monophosphate—PDE4B—endocrine gland—polycystic ovary syndrome	0.00035	0.00279	CbGeAlD
Adenosine monophosphate—PDE4B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.85e-06	5.25e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.81e-06	5.22e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—NGFR—polycystic ovary syndrome	9.8e-06	5.22e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—IRS2—polycystic ovary syndrome	9.77e-06	5.2e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—POMC—polycystic ovary syndrome	9.74e-06	5.19e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—NCOR1—polycystic ovary syndrome	9.74e-06	5.18e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—PRL—polycystic ovary syndrome	9.71e-06	5.17e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—GNAS—polycystic ovary syndrome	9.67e-06	5.15e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—INSR—polycystic ovary syndrome	9.64e-06	5.13e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—BCL2—polycystic ovary syndrome	9.57e-06	5.09e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—SERPINE1—polycystic ovary syndrome	9.55e-06	5.08e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL18—polycystic ovary syndrome	9.42e-06	5.02e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—AKT2—polycystic ovary syndrome	9.36e-06	4.98e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—NGFR—polycystic ovary syndrome	9.32e-06	4.96e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PDE3B—polycystic ovary syndrome	9.3e-06	4.95e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—NRG1—polycystic ovary syndrome	9.27e-06	4.93e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—POMC—polycystic ovary syndrome	9.26e-06	4.93e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IRS1—polycystic ovary syndrome	9.24e-06	4.92e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—PRL—polycystic ovary syndrome	9.24e-06	4.92e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—FGF18—polycystic ovary syndrome	9.24e-06	4.92e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—CYP1A1—polycystic ovary syndrome	9.23e-06	4.91e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—GNAS—polycystic ovary syndrome	9.23e-06	4.91e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—ADRB2—polycystic ovary syndrome	9.22e-06	4.91e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.22e-06	4.91e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—NRG1—polycystic ovary syndrome	9.22e-06	4.91e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	9.16e-06	4.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—RBP4—polycystic ovary syndrome	9.16e-06	4.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—GAB1—polycystic ovary syndrome	9.14e-06	4.86e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.05e-06	4.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	9.04e-06	4.81e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	9.02e-06	4.8e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by SCF-KIT—IL6—polycystic ovary syndrome	8.95e-06	4.77e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PGR—polycystic ovary syndrome	8.93e-06	4.75e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IRS1—polycystic ovary syndrome	8.93e-06	4.75e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.91e-06	4.74e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—NRG1—polycystic ovary syndrome	8.9e-06	4.74e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—LEP—polycystic ovary syndrome	8.8e-06	4.68e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.79e-06	4.68e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.77e-06	4.67e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by NGF—IL6—polycystic ovary syndrome	8.68e-06	4.62e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—NCOR1—polycystic ovary syndrome	8.67e-06	4.61e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—NRG1—polycystic ovary syndrome	8.63e-06	4.59e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—MTHFR—polycystic ovary syndrome	8.6e-06	4.58e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—POMC—polycystic ovary syndrome	8.6e-06	4.58e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—AKT2—polycystic ovary syndrome	8.55e-06	4.55e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—INS—polycystic ovary syndrome	8.55e-06	4.55e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—GNAS—polycystic ovary syndrome	8.55e-06	4.55e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—IRS1—polycystic ovary syndrome	8.53e-06	4.54e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—NRG1—polycystic ovary syndrome	8.51e-06	4.53e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FSHR—polycystic ovary syndrome	8.47e-06	4.51e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—GAB1—polycystic ovary syndrome	8.44e-06	4.49e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CAMK2D—polycystic ovary syndrome	8.3e-06	4.42e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PLAT—polycystic ovary syndrome	8.3e-06	4.42e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—GHRL—polycystic ovary syndrome	8.3e-06	4.42e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IGF1—polycystic ovary syndrome	8.27e-06	4.4e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—AKT2—polycystic ovary syndrome	8.26e-06	4.4e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—NAMPT—polycystic ovary syndrome	8.22e-06	4.38e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—TNRC6B—polycystic ovary syndrome	8.17e-06	4.35e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—INS—polycystic ovary syndrome	8.17e-06	4.35e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—NCOR1—polycystic ovary syndrome	8.14e-06	4.33e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—GNAS—polycystic ovary syndrome	8.13e-06	4.33e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—VEGFA—polycystic ovary syndrome	8.1e-06	4.31e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Downstream signal transduction—IL6—polycystic ovary syndrome	8.05e-06	4.29e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by FGFR—IL6—polycystic ovary syndrome	8.01e-06	4.27e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—NRG1—polycystic ovary syndrome	7.99e-06	4.25e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by ERBB2—IL6—polycystic ovary syndrome	7.97e-06	4.24e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—RACGAP1—polycystic ovary syndrome	7.96e-06	4.24e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—IRS2—polycystic ovary syndrome	7.94e-06	4.23e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—CRP—polycystic ovary syndrome	7.94e-06	4.23e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—ATF1—polycystic ovary syndrome	7.92e-06	4.22e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—AKT2—polycystic ovary syndrome	7.9e-06	4.2e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—CRP—polycystic ovary syndrome	7.89e-06	4.2e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IRS2—polycystic ovary syndrome	7.89e-06	4.2e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Axon guidance—IL6—polycystic ovary syndrome	7.86e-06	4.18e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	7.85e-06	4.18e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IRS2—polycystic ovary syndrome	7.75e-06	4.13e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.74e-06	4.12e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ADRA1A—polycystic ovary syndrome	7.74e-06	4.12e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	7.72e-06	4.11e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—AKR1C3—polycystic ovary syndrome	7.66e-06	4.08e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—PPARG—polycystic ovary syndrome	7.66e-06	4.08e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—MTHFR—polycystic ovary syndrome	7.66e-06	4.08e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—IRS2—polycystic ovary syndrome	7.62e-06	4.06e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—NRG1—polycystic ovary syndrome	7.6e-06	4.05e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—LEP—polycystic ovary syndrome	7.58e-06	4.04e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FST—polycystic ovary syndrome	7.55e-06	4.02e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—TNRC6B—polycystic ovary syndrome	7.55e-06	4.02e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—INS—polycystic ovary syndrome	7.51e-06	4e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—SERPINE1—polycystic ovary syndrome	7.51e-06	4e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—BCL2—polycystic ovary syndrome	7.47e-06	3.98e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by FGFR in disease—IL6—polycystic ovary syndrome	7.46e-06	3.97e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ADRB3—polycystic ovary syndrome	7.45e-06	3.97e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by EGFR—IL6—polycystic ovary syndrome	7.4e-06	3.94e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IRS2—polycystic ovary syndrome	7.39e-06	3.94e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—LHB—polycystic ovary syndrome	7.37e-06	3.92e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by EGFR in Cancer—IL6—polycystic ovary syndrome	7.33e-06	3.9e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—NGFR—polycystic ovary syndrome	7.31e-06	3.89e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by PDGF—IL6—polycystic ovary syndrome	7.3e-06	3.89e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—IRS2—polycystic ovary syndrome	7.29e-06	3.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—AKT2—polycystic ovary syndrome	7.26e-06	3.87e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—POMC—polycystic ovary syndrome	7.26e-06	3.87e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—PRL—polycystic ovary syndrome	7.24e-06	3.86e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—LEP—polycystic ovary syndrome	7.23e-06	3.85e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—GNRH1—polycystic ovary syndrome	7.2e-06	3.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—ATF1—polycystic ovary syndrome	7.17e-06	3.82e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—IGF1—polycystic ovary syndrome	7.13e-06	3.8e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—AKT2—polycystic ovary syndrome	7.13e-06	3.79e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—AKT2—polycystic ovary syndrome	6.98e-06	3.72e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—PPARG—polycystic ovary syndrome	6.98e-06	3.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—AKR1C1—polycystic ovary syndrome	6.97e-06	3.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—IRS1—polycystic ovary syndrome	6.93e-06	3.69e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—SCT—polycystic ovary syndrome	6.9e-06	3.67e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IRS1—polycystic ovary syndrome	6.89e-06	3.67e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—POMC—polycystic ovary syndrome	6.88e-06	3.66e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—ADRB2—polycystic ovary syndrome	6.87e-06	3.66e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.84e-06	3.64e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Metabolism—INS—polycystic ovary syndrome	6.84e-06	3.64e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—SERPINE1—polycystic ovary syndrome	6.77e-06	3.6e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IRS1—polycystic ovary syndrome	6.76e-06	3.6e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—LEP—polycystic ovary syndrome	6.7e-06	3.57e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—IRS1—polycystic ovary syndrome	6.65e-06	3.54e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—VEGFA—polycystic ovary syndrome	6.65e-06	3.54e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Innate Immune System—IL6—polycystic ovary syndrome	6.64e-06	3.54e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—TAB1—polycystic ovary syndrome	6.62e-06	3.53e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—NGF signalling via TRKA from the plasma membrane—IL6—polycystic ovary syndrome	6.61e-06	3.52e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—MTNR1B—polycystic ovary syndrome	6.58e-06	3.51e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—VEGFA—polycystic ovary syndrome	6.57e-06	3.5e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—PRL—polycystic ovary syndrome	6.56e-06	3.49e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—POMC—polycystic ovary syndrome	6.51e-06	3.47e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IRS2—polycystic ovary syndrome	6.51e-06	3.47e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—INS—polycystic ovary syndrome	6.48e-06	3.45e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—FGF18—polycystic ovary syndrome	6.47e-06	3.44e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—TCF7L2—polycystic ovary syndrome	6.46e-06	3.44e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IRS1—polycystic ovary syndrome	6.45e-06	3.44e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—RBP4—polycystic ovary syndrome	6.42e-06	3.42e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—AKT2—polycystic ovary syndrome	6.41e-06	3.42e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—AKT2—polycystic ovary syndrome	6.38e-06	3.4e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—GNAS—polycystic ovary syndrome	6.37e-06	3.39e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—LEP—polycystic ovary syndrome	6.37e-06	3.39e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—IRS1—polycystic ovary syndrome	6.36e-06	3.39e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—SLC2A4—polycystic ovary syndrome	6.35e-06	3.38e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.27e-06	3.34e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.26e-06	3.33e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—POMC—polycystic ovary syndrome	6.21e-06	3.31e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—INS—polycystic ovary syndrome	6.18e-06	3.29e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Adaptive Immune System—AKT2—polycystic ovary syndrome	6.16e-06	3.28e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—INS—polycystic ovary syndrome	6.09e-06	3.24e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—NCOR1—polycystic ovary syndrome	6.07e-06	3.23e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—PRL—polycystic ovary syndrome	6.06e-06	3.23e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—YAP1—polycystic ovary syndrome	5.99e-06	3.19e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IGF1—polycystic ovary syndrome	5.98e-06	3.18e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.98e-06	3.18e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—AKT2—polycystic ovary syndrome	5.97e-06	3.18e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—NRG1—polycystic ovary syndrome	5.96e-06	3.17e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.95e-06	3.17e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—GAB1—polycystic ovary syndrome	5.91e-06	3.15e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—AKT2—polycystic ovary syndrome	5.89e-06	3.14e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—POMC—polycystic ovary syndrome	5.75e-06	3.06e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—INS—polycystic ovary syndrome	5.72e-06	3.05e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IRS1—polycystic ovary syndrome	5.68e-06	3.03e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.68e-06	3.02e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—INSR—polycystic ovary syndrome	5.65e-06	3.01e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Developmental Biology—IL6—polycystic ovary syndrome	5.61e-06	2.98e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—BCL2—polycystic ovary syndrome	5.6e-06	2.98e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—SERPINE1—polycystic ovary syndrome	5.6e-06	2.98e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—BCL2—polycystic ovary syndrome	5.57e-06	2.97e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.53e-06	2.95e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.53e-06	2.94e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL18—polycystic ovary syndrome	5.52e-06	2.94e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—POMC—polycystic ovary syndrome	5.47e-06	2.91e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—INS—polycystic ovary syndrome	5.44e-06	2.9e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	5.4e-06	2.88e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—NRG1—polycystic ovary syndrome	5.4e-06	2.87e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—AKR1C3—polycystic ovary syndrome	5.37e-06	2.86e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TNRC6B—polycystic ovary syndrome	5.28e-06	2.81e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IGF1—polycystic ovary syndrome	5.26e-06	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—AKT2—polycystic ovary syndrome	5.26e-06	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.26e-06	2.8e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PGR—polycystic ovary syndrome	5.23e-06	2.78e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IRS2—polycystic ovary syndrome	5.1e-06	2.72e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling by NGF—IL6—polycystic ovary syndrome	5.08e-06	2.71e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—NCOR1—polycystic ovary syndrome	5.08e-06	2.7e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5e-06	2.66e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—LEP—polycystic ovary syndrome	4.99e-06	2.66e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—NRG1—polycystic ovary syndrome	4.98e-06	2.65e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Innate Immune System—IL6—polycystic ovary syndrome	4.95e-06	2.64e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PLAT—polycystic ovary syndrome	4.86e-06	2.59e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—GHRL—polycystic ovary syndrome	4.86e-06	2.59e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—VEGFA—polycystic ovary syndrome	4.75e-06	2.53e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Hemostasis—VEGFA—polycystic ovary syndrome	4.66e-06	2.48e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ATF1—polycystic ovary syndrome	4.64e-06	2.47e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—CRP—polycystic ovary syndrome	4.62e-06	2.46e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IRS2—polycystic ovary syndrome	4.62e-06	2.46e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Axon guidance—IL6—polycystic ovary syndrome	4.6e-06	2.45e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling by GPCR—IL6—polycystic ovary syndrome	4.57e-06	2.43e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB2—Signaling Pathways—IL6—polycystic ovary syndrome	4.54e-06	2.42e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—TCF7L2—polycystic ovary syndrome	4.52e-06	2.41e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—MTHFR—polycystic ovary syndrome	4.49e-06	2.39e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IRS1—polycystic ovary syndrome	4.46e-06	2.37e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—POMC—polycystic ovary syndrome	4.29e-06	2.28e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NGFR—polycystic ovary syndrome	4.28e-06	2.28e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IRS2—polycystic ovary syndrome	4.27e-06	2.27e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—INS—polycystic ovary syndrome	4.27e-06	2.27e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—PRL—polycystic ovary syndrome	4.24e-06	2.26e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.23e-06	2.25e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IGF1—polycystic ovary syndrome	4.13e-06	2.2e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—AKT2—polycystic ovary syndrome	4.12e-06	2.2e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.09e-06	2.18e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IRS1—polycystic ovary syndrome	4.04e-06	2.15e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling by GPCR—IL6—polycystic ovary syndrome	4.03e-06	2.14e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—ADRB2—polycystic ovary syndrome	4.03e-06	2.14e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	3.92e-06	2.09e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.9e-06	2.08e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Immune System—IL6—polycystic ovary syndrome	3.87e-06	2.06e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—AKT2—polycystic ovary syndrome	3.74e-06	1.99e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAB1—Signaling Pathways—IL6—polycystic ovary syndrome	3.74e-06	1.99e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—GNAS—polycystic ovary syndrome	3.73e-06	1.99e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IRS1—polycystic ovary syndrome	3.73e-06	1.98e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.62e-06	1.92e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Disease—IL6—polycystic ovary syndrome	3.57e-06	1.9e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—INS—polycystic ovary syndrome	3.57e-06	1.9e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NCOR1—polycystic ovary syndrome	3.56e-06	1.89e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—NRG1—polycystic ovary syndrome	3.49e-06	1.86e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—AKT2—polycystic ovary syndrome	3.45e-06	1.84e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.44e-06	1.83e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Developmental Biology—IL6—polycystic ovary syndrome	3.28e-06	1.75e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—SERPINE1—polycystic ovary syndrome	3.28e-06	1.75e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—BCL2—polycystic ovary syndrome	3.26e-06	1.74e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling by GPCR—IL6—polycystic ovary syndrome	3.16e-06	1.68e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IRS2—polycystic ovary syndrome	2.99e-06	1.59e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—LEP—polycystic ovary syndrome	2.93e-06	1.56e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Innate Immune System—IL6—polycystic ovary syndrome	2.9e-06	1.54e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Immune System—IL6—polycystic ovary syndrome	2.88e-06	1.54e-05	CbGpPWpGaD
Adenosine monophosphate—PRKAA1—Signaling Pathways—IL6—polycystic ovary syndrome	2.83e-06	1.51e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4D—Signaling Pathways—IL6—polycystic ovary syndrome	2.7e-06	1.44e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—VEGFA—polycystic ovary syndrome	2.7e-06	1.44e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Disease—IL6—polycystic ovary syndrome	2.66e-06	1.42e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IRS1—polycystic ovary syndrome	2.61e-06	1.39e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—POMC—polycystic ovary syndrome	2.51e-06	1.34e-05	CbGpPWpGaD
Adenosine monophosphate—ADCY1—Signaling Pathways—IL6—polycystic ovary syndrome	2.5e-06	1.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—INS—polycystic ovary syndrome	2.5e-06	1.33e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IGF1—polycystic ovary syndrome	2.42e-06	1.29e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—AKT2—polycystic ovary syndrome	2.42e-06	1.29e-05	CbGpPWpGaD
Adenosine monophosphate—PDE4B—Signaling Pathways—IL6—polycystic ovary syndrome	2.38e-06	1.27e-05	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—SERPINE1—polycystic ovary syndrome	2.3e-06	1.22e-05	CbGpPWpGaD
Adenosine monophosphate—CREB1—Signaling Pathways—IL6—polycystic ovary syndrome	1.86e-06	9.93e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Immune System—IL6—polycystic ovary syndrome	1.69e-06	8.99e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.58e-06	8.41e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Disease—IL6—polycystic ovary syndrome	1.56e-06	8.3e-06	CbGpPWpGaD
Adenosine monophosphate—SRC—Signaling Pathways—IL6—polycystic ovary syndrome	1.09e-06	5.81e-06	CbGpPWpGaD
